The Synthetics, Part II: Designer Drugs on the Horizon

November 14, 2019

Daniela Zaborskis, PhD
Director of Operations and Senior Scientist, Acutis Diagnostics


Mumtaz Akhtar, MS
Senior Researcher, Acutis Diagnostics

Learning Objectives

At the end of this presentation, participants should be better able to:

• Describe the pharmacology of kratom and designer benzodiazepines.
• Review of the overdose potential of kratom and designer benzodiazepines amongst commonly abused substances.
• Review of the legal status of kratom and designer benzodiazepines in the United States.
• Describe the ease of access to kratom and designer benzodiazepines.
• Review of the current state of detection methodologies to detect kratom and designer benzodiazepines.
 
 
Course summary
Available credit: 
  • 1.00 AANP
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
Course opens: 
11/14/2019
Course expires: 
12/31/2019
Event starts: 
11/14/2019 - 12:00pm
Event ends: 
11/14/2019 - 1:00pm
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.00 AANP
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance

Accreditation Period

Course opens: 
11/14/2019
Course expires: 
12/31/2019

Price

Cost:
$0.00
Please login or register to take this course.